Esquire Financial Holdings, Inc. (ESQ) director granted 1,836 restricted stock

Rhea-AI Filing Summary

Esquire Financial Holdings, Inc. reported an insider equity award by one of its directors. On 12/10/2025, the director acquired 1,836 shares of common stock as restricted stock at a price of $0. These restricted shares vest 100% on December 10, 2026.

Following this grant, the director beneficially owns 49,267 shares of common stock directly, 12,910 shares indirectly through a trust, and 36,000 shares indirectly through an IRA. The director also holds fully vested stock options covering 20,000 shares of common stock with an exercise price of $12.5 per share, expiring on 09/01/2026.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Coelho Anthony

(Last) (First) (Middle)

100 JERICHO QUADRANGLE

SUITE 100

(Street)

JERICHO NY 11753

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Esquire Financial Holdings, Inc. [ ESQ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/10/2025		A		1,836(1)	A	$0	49,267(2)(3)(4)(5)(6)(7)	D
Common Stock								12,910	I	By Trust
Common Stock								36,000	I	By IRA

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options	$12.5							09/01/2017	09/01/2026	Common Stock	20,000(8)		20,000(8)	D

Explanation of Responses:

1. Shares of restricted stock vest 100% on December 10, 2026.

2. Includes shares of restricted stock which vest in three equal annual installments commencing on December 19, 2023.

3. Includes shares of restricted stock which vest in three equal annual installments commencing on December 16, 2024.

4. Includes shares of restricted stock which vest in three equal annual installments commencing on December 9, 2025.

5. Includes shares of restricted stock which vest in three equal annual installments commencing on December 19, 2026.

6. Includes shares of restricted stock which vest in three equal annual installments commencing on December 3, 2027.

7. Includes shares of restricted stock which vest in three equal annual installments commencing on December 15, 2027.

8. Stock options are fully vested.

	/s/ Eric S. Bader, pursuant to power of attorney	12/16/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Esquire Financial Holdings (ESQ) report?

A director of Esquire Financial Holdings, Inc. reported acquiring 1,836 shares of common stock as restricted stock on 12/10/2025 at a price of $0 per share.

When do the newly granted 1,836 restricted shares of ESQ stock vest?

The 1,836 restricted shares of Esquire Financial common stock vest 100% on December 10, 2026, according to the filing’s explanation.

How many ESQ shares does the director own after this Form 4 transaction?

After the reported transaction, the director beneficially owns 49,267 shares directly, 12,910 shares indirectly through a trust, and 36,000 shares indirectly through an IRA.

What stock options does the Esquire Financial director hold?

The director holds fully vested stock options on 20,000 shares of common stock with an exercise price of $12.5 per share, expiring on 09/01/2026.

What is the director’s relationship to Esquire Financial Holdings (ESQ)?

The reporting person is identified as a Director of Esquire Financial Holdings, Inc. and filed the Form 4 as a single reporting person.

Are the reported ESQ stock options already vested?

Yes. The filing states that the stock options are fully vested, covering 20,000 shares of Esquire Financial common stock.